Click it and Unblock the Notifications
Latest Updates
-
OTT Releases This Week (October 19–25): New Movies And Series On Netflix, Prime Video, JioHotstar And Zee5 -
Police Commemoration Day 2026: Know The History, Significance And Programmes Planned Across India This Year -
Deepika Padukone And Ranveer Singh Announce Second Daughter’s Name On Dussehra, Share Family Photo -
Who Was Karthik Sabesh? Tamil Actor Passes Away At 37, Days After Uncle And Composer Deva’s Death -
Who Is Ravleen Varghese? Meet The First Malayali Model To Walk The Victoria’s Secret Runway -
World Osteoporosis Day 2026: A Minor Fall, A Major Fracture — Doctor On Why Older Adults Should Be Careful -
Durga Visarjan 2026: October 20 or 21? Know Shubh Muhurat, Rituals And Significance -
Happy Dussehra 2026: 50+ Wishes, Messages And Greetings To Share With Family And Friends -
Dussehra 2026: Astrologer Ashutosh Clairvoyant On Colours, Offerings And Puja Rituals For Each Zodiac Sign -
Hustle Culture Has a Bedroom Problem No One Talks About, Expert Explains
COVID-19 Vaccination: Supply, Eligibility Will Decide Vax For Kids
The government will take a final decision on vaccinating children and adolescents against coronavirus on the basis of overall scientific rationale as well as the supply situation of vaccines available for those below 18 years, Covid task force chief V K Paul said on Sunday.
Paul also cautioned that even though infections were coming down and the second wave was subsiding, it would not be fair to say that the worst was over since many countries had seen more than two waves.
Currently, three vaccines - Covishield, Covaxin and Sputnik V - being administered in the country are only for those above 18. Zydus Cadila's needle-free vaccine ZyCoV-D is set to become the first that will be available in India for those between 12 and 18. It has received emergency use authorisation (EUA).
"We do know several countries have introduced vaccination for adolescents and children. We will make a final decision based on the overall scientific rationale and the supply situation of the child-licenced vaccines," Paul said.
An expert panel of India's central drug authority has recommended granting EUA to Bharat Biotech's Covaxin for children and adolescents in the 2-18 age group with certain conditions.
According to Paul, Covaxin is part of the adult vaccination programme and how to provide the vaccine, if at all for children, has to be also examined.
"A pragmatic decision can be taken (only) by balancing the supply and the potential eligibility," he said.
Paul said: "The preparation for incorporation of Zydus Cadila's vaccine into the vaccination programme is proceeding well, training is already being held."
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google
